Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cascinu

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
Tumori|July 25, 1998
Chemotherapy for advanced pancreatic cancer: the history is changingF Graziano, G Catalano, S Cascinu
British Journal of Cancer|January 1, 1995
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapyS Cascinu, E Del Ferro, G Catalano
Anti-Cancer Drugs|January 1, 1996
Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized studyS Cascinu, E Del Ferro, G Catalano
American Journal of Clinical Oncology|August 1, 1996
Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancerS Cascinu, E Del Ferro, G Catalano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Pre-operative treatment modalities in gastric cancer patientsM Scartozzi, R Berardi, C Pierantoni, et al.
International Journal of Oncology|May 17, 2011
Intensive weekly chemotherapy for advanced gastric-cancer using 5-Fluorouracil, Cisplatin, epi-Doxorubicin, 6s-leucovorin and granulocyte-colony-stimulating factorS Cascinu, A Fedeli, S Fedeli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upS Cascinu, M Falconi, V Valentini, et al.
Critical Reviews in Oncology/Hematology|April 20, 2001
Molecular markers predictive of response to chemotherapy in gastrointestinal tumorsV Catalano, A M Baldelli, P Giordani, et al.
British Journal of Cancer|February 1, 1994
Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancerS Cascinu, A Fedeli, S Luzi Fedeli, et al.
Anti-Cancer Drugs|July 1, 1996
A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinomaS Cascinu, E Del Ferro, M Ligi, et al.
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
Tumori|July 25, 1998
Chemotherapy for advanced pancreatic cancer: the history is changingF Graziano, G Catalano, S Cascinu
British Journal of Cancer|January 1, 1995
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapyS Cascinu, E Del Ferro, G Catalano
Anti-Cancer Drugs|January 1, 1996
Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized studyS Cascinu, E Del Ferro, G Catalano
American Journal of Clinical Oncology|August 1, 1996
Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancerS Cascinu, E Del Ferro, G Catalano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Pre-operative treatment modalities in gastric cancer patientsM Scartozzi, R Berardi, C Pierantoni, et al.
International Journal of Oncology|May 17, 2011
Intensive weekly chemotherapy for advanced gastric-cancer using 5-Fluorouracil, Cisplatin, epi-Doxorubicin, 6s-leucovorin and granulocyte-colony-stimulating factorS Cascinu, A Fedeli, S Fedeli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upS Cascinu, M Falconi, V Valentini, et al.
Critical Reviews in Oncology/Hematology|April 20, 2001
Molecular markers predictive of response to chemotherapy in gastrointestinal tumorsV Catalano, A M Baldelli, P Giordani, et al.
British Journal of Cancer|February 1, 1994
Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancerS Cascinu, A Fedeli, S Luzi Fedeli, et al.
Anti-Cancer Drugs|July 1, 1996
A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinomaS Cascinu, E Del Ferro, M Ligi, et al.
Pageof 19